

Top 3 Episodes of 2022 - #1 Dame Kate Bingham (Managing Partner of SV Health Investors)
Mar 22, 2023
Dame Kate Bingham, Managing Partner of SV Health Investors, discusses advancements in medical research, challenges in building biotech enterprises, and her role in the UK Vaccine Taskforce. She reflects on obstacles faced during the COVID-19 vaccine distribution and the future of the industry landscape.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7
Intro
00:00 • 3min
Journey from Academia to Venture Capital in Biotech & Healthcare
02:57 • 20min
Preferred Clients and Investors in Healthcare and Biotech Investments
23:11 • 4min
Progress in Dementia Research and Comparison to Cancer Research
26:45 • 4min
Venture Capital and Healthcare Innovation
30:37 • 5min
Encouraging STEM Education and Vaccine Task Force Journey
36:03 • 3min
Challenges and Decisions in Vaccine Development
38:51 • 18min